Anixa Biosciences (ANIX) Total Non-Current Liabilities (2013 - 2017)

Anixa Biosciences (ANIX) has reported Total Non-Current Liabilities for 5 consecutive years, with $3.7 million the latest figure, recorded in Q1 2017.

• For the quarter ending Q1 2017, Total Non-Current Liabilities rose 199.35% year-over-year to $3.7 million; the trailing twelve-month figure through Jan 2017 stood at $3.7 million (up 199.35% YoY), and the FY2016 full-year result was $468756.0, down 21.06% from the prior year.
• Total Non-Current Liabilities advanced to $3.7 million in Q1 2017 per ANIX's latest filing, from $468756.0 in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $12.6 million in Q1 2014 and bottomed at $468756.0 in Q4 2016.
• Historically, Total Non-Current Liabilities has averaged $4.5 million across 5 years, with a median of $1.7 million in 2014.
• The sharpest annual moves came in 2015 and 2017: Total Non-Current Liabilities sank 94.41% in 2015, then jumped 199.35% in 2017.
• Over 5 years, Total Non-Current Liabilities stood at $8.2 million in 2013, then sank by 77.99% to $1.8 million in 2014, then tumbled by 67.19% to $593782.0 in 2015, then fell by 21.06% to $468756.0 in 2016, then jumped by 694.43% to $3.7 million in 2017.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.7 million, $468756.0, and $531624.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.